Seeking Alpha

Oncology treatment specialist Geron (GERN +14.3%) zooms higher, perhaps due to a positive...

Oncology treatment specialist Geron (GERN +14.3%) zooms higher, perhaps due to a positive Seeking Alpha blog which recommends purchase for investors with room for some speculation in their portfolios. Geron's drugs "have the potential to change the way cancer is treated," the article says, citing six potential catalysts for GERN's stock over the next year.
Comments (1)
  • p0zz
    , contributor
    Comments (27) | Send Message
     
    I would hope articles dont have such power, even tough linked trough Yahoo finance and such ..
    16 Aug 2012, 02:09 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs